The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Astellas Amgen BioPharama; Bayer; Janssen

Estrogen receptor β and TMPRSS2-ERG expression association with clinical outcomes in metastatic hormone-sensitive prostate cancer.
 
Caterina Aversa
Speakers' Bureau - AstraZeneca Spain; Janssen; MSD
Research Funding - Janssen
 
Natalia Jiménez
No Relationships to Disclose
 
Mercedes Marin
No Relationships to Disclose
 
Laura Ferrer-Mileo
Speakers' Bureau - Kyowa Kirin; Pfizer
Travel, Accommodations, Expenses - Kyowa Kirin; Pfizer
 
Oscar Reig
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Leonardo Rodriguez-Carunchio
No Relationships to Disclose
 
Albert Font
Consulting or Advisory Role - Astellas Amgen BioPharama; AstraZeneca Spain; Ipsen; Janssen; Roche; Sanofi
Research Funding - Astellas Amgen BioPharama; AstraZeneca Spain; Pierre Fabre
Travel, Accommodations, Expenses - Janssen; Roche; Sanofi
 
Alejo Rodriguez-Vida
Consulting or Advisory Role - Astellas Oncology; AstraZeneca Spain; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; MSD; Pfizer; Roche; Sanofi
Research Funding - Merck; Pfizer; Takeda
 
Montserrat Domenech-Santasusana
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Lilly; Sanofi
 
Mariona Figols
Consulting or Advisory Role - Ipsen; Pfizer
Travel, Accommodations, Expenses - Merck
 
Miguel Angel Climent Duran
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche
 
Sara Cros Costa
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merck; Pfizer; Roche; Tesaro
Research Funding - Janssen; Pfizer
 
Isabel Chirivella
Consulting or Advisory Role - Astellas Amgen BioPharama; AstraZeneca Spain; Bayer; Janssen; Novartis; Sanofi Aventis GmbH
Travel, Accommodations, Expenses - Janssen; Novartis Pharmaceuticals UK Ltd.; Sanofi
 
Daniel Herrero Rivera
Honoraria - Kyowa Kirin; Leo Pharma; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Kyowa Kirin; MSD; Pfizer; ROVI
 
Enrique Gonzalez -Billalabeitia
No Relationships to Disclose
 
Daniel Jiménez-Peralta
No Relationships to Disclose
 
Joan Carles
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZéneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson/Janssen; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson
Research Funding - AB Science (Inst); Aragon Pharmaceuticals (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); BN ImmunoTherapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera; Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen-Cilag International NV (Inst); Karyopharm Therapeutics (Inst); Laboratories Leurquin Mediolanum (Inst); Lilly (Inst); Medimmune (Inst); Millenium Pharamceuticals (Inst); Nanobiotix (Inst); Novartis Farmacéutica SA (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi Aventis GmbH (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; Roche
 
Cristina Suárez
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Sharp & Dohme; Pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Research Funding - AB Science (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Millennium (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Roche
 
Aleix Prat
Employment - Novartis (I)
Stock and Other Ownership Interests - Reveal Genomics
Honoraria - Amgen; Daiichi Sankyo; Guardant Health; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; NanoString Technologies (Inst); Novartis; Oncolytics; Pfizer; Puma Biotechnology; Roche
Research Funding - Incyte (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - HER2DX filing; METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE (US 63/023785); PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; WO/2018/096191. Chemoendocrine score (CES) Based on PAM50 for breast cancer with positive hormone receptors with an intermediate risk of recurrence
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc
 
Begona Mellado
Speakers' Bureau - Astellas Amgen BioPharama; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer; Janssen; Pfizer/Calithera; Roche
Travel, Accommodations, Expenses - Janssen; Pfizer